• Profile
Close

Association of combined naltrexone and ketamine with depressive symptoms in a case series of patients with depression and alcohol use disorder

JAMA Psychiatry Mar 15, 2019

Yoon G, et al. - Researchers suggest the possible efficacy of opiate receptor antagonism combined with ketamine in reducing addiction risk among patients with depression at risk for substance abuse. While ketamine has rapid and robust antidepressant effects, the abuse liability of ketamine is concerning, even more so with a preliminary report suggesting that antidepressant effects of ketamine might depend on opiate receptor stimulation. The presented pilot data suggest that naltrexone pretreatment does not reduce the antidepressant effects of ketamine.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay